According to FutureWise analysis the market for infectious disease testing in 2023 is US$ 25.37 billion, and is expected to reach US$ 39.59 billion by 2031 at a CAGR of 5.72%.
Infectious disease is caused by bacteria, virus and others and has a huge impact on healthcare systems of the countries. Infectious disease testing is the process of identification of causative organism for the primary diagnosis of diseases.Infectious diseases testing samples include blood, urine and other bodily fluids. Diagnosis is primary requisite for disease management, so infectious disease testing plays a very important role in primary healthcare settings.
Increasing epidemics of infectious diseases require continuous testing and led robust growth of the market. Infectious diseases have a huge impact on healthcare systems due to high disease burden. Because of this, government bodies made it mandatory to run infectious disease testing across different domains. It created potential opportunities for infectious disease testing manufacturers and boosted the growth of the market. Further, changing regulatory policies to mandate the infectious disease testing for the general population fuelled the growth of the market. Along with these, technology has integrated the existing manual operations and led to the development of a fully automated process. Others factors like increasing awareness among the general population regarding the drastic effects of infectious diseases have boosted the robust growth of the infectious disease testing market.
Developing economies made it mandatory for testing the general population regarding the infectious disease epidemics has boosted the growth of North America and Europe. North America infectious disease testing market accounts major share in the global market due to high penetration among the end users. It is followed by Europe and it witnessed a significant share due to stringent government policies. Asia Pacific and Latin America Infectious Disease Testing market is the most lucrative space for manufacturers due to high prevalence of infectious diseases. Rest of the world witnessed significant growth during the forecast period due to increasing awareness.